Open main menu - A Hematology Oncology Wiki β

Caplacizumab (Cablivi)


Mechanism of action

A single domain antibody directed against the A1 domain of von Willebrand factor (vWF).

Diseases for which it is used

History of changes in FDA indication

Also known as

  • Code name: ALX-0081
  • Generic name: caplacizumab-yhdp
  • Brand name: Cablivi